Back
Bicara Therapeutics Vs. Summit Midstream Industry Stock Comparison
Sell
1
BCAX
Bicara Therapeutics
Last Price:
$9.36
Seasonality Move:
--
Sell
19
SMC
Summit Midstream
Last Price:
$27.25
Seasonality Move:
16.79%
Sell
1
Bicara Therapeutics (BCAX)
is a Sell
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $9.51. The Score for BCAX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
BCAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
Summit Midstream (SMC)
is a Sell
Is Summit Midstream a Buy, Sell or Hold?
-
The current Summit Midstream [SMC] share price is $26.72. The Score for SMC is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
SMC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $9.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing slight selling pressure.
SMC Stock Price Chart
What is Summit Midstream's stock price today?
-
The Summit Midstream share price today is $26.72Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMC is experiencing selling pressure, which indicates risk of future bearish movement.
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 31.11 | Sell |
Chaikin Money Flow: | -177722 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.78 - 14.54) | Sell |
Bollinger Bands (100): | (12 - 18.98) | Sell |
SMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.61 | Sell |
Relative Strength Index (14 RSI): | 24.44 | Sell |
Chaikin Money Flow: | -325131 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.96 - 39.52) | Sell |
Bollinger Bands (100): | (34.95 - 41.93) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.21 | Sell |
20-day SMA: | 12.78 | Sell |
50-day SMA: | 12.9 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 11.71 | Sell |
20-day EMA: | 12.55 | Sell |
50-day EMA: | 13.33 | Sell |
200-day EMA: | 11.35 | Sell |
SMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.69 | Sell |
20-day SMA: | 35.31 | Sell |
50-day SMA: | 39.59 | Sell |
200-day SMA: | 37.15 | Sell |
8-day EMA: | 31.93 | Sell |
20-day EMA: | 34.88 | Sell |
50-day EMA: | 37.5 | Sell |
200-day EMA: | 35.85 | Sell |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.
Summit Midstream Earnings Growth & SMC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bicara Therapeutics Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Midstream Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |